Making pediatric cancer more 'visible' boosts immunotherapy response

Дата публикации: 05-10-2026 20:00:02

High-risk neuroblastoma is one of the most aggressive forms of solid tumors affecting children, originating in the nervous system. While a newer class of targeted immunotherapy drugs has improved survival rates, according to the American Cancer Society, cancer can hide from the immune system, causing patients to relapse or develop resistance to treatment. Now, a team of researchers from Penn State College of Medicine has discovered a novel strategy to unmask cancer cells, improving the effectiveness of immunotherapy in cell experiments and mouse models.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Scientists identify the neuroblastoma cells that signal poor outcomes	0	5.86	08-10-2026
2	Making invisible cancers visible: A new route to turn 'cold' tumors 'hot'	0	7.83	17-09-2026
3	Scientists uncover two-pronged strategy to overcome glioblastoma's resistance to immunotherapy	0	9.78	08-10-2026
4	Hidden “immune organ” in the skull may help fight brain cancer	0	5.41	17-09-2026
5	Drug Used to Treat Asthma and Allergies May Also Help Fight Aggressive Cancers	0	5.67	24-05-2026
6	Увеличена эффективность иммунотерапии против рака мозга	0	12.74	08-10-2026
7	Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer	0	7.48	23-09-2026
8	Нервы помогают опухолям прятаться от иммунитета, объяснили ученые	0	7.48	07-10-2026
9	Scientists find a way to break pancreatic cancer’s protective shield	0	12.01	12-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 6.44. Источник: medicalxpress.com.